Talphera, Inc. (TLPH) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.83. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 3 out of 7 criteria passed.
Valuation: TLPH trades at a trailing Price-to-Earnings (P/E) of -2.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.16.
Financials: revenue is $28,000, -81.6%/yr average growth. Net income is $14M (loss), growing at -39.7%/yr. Net profit margin is -51035.7% (negative). Gross margin is 100% (+146.3 pp trend).
Balance sheet: total debt is $6M against $17M equity (Debt-to-Equity (D/E) ratio 0.38, conservative). Current ratio is 5.49 (strong liquidity). Debt-to-assets is 21.9%. Total assets: $30M.
Analyst outlook: 1 / 1 analysts rate TLPH as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 25/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).
